Department of Pharmaceutics, Shenyang Pharmaceutical University , Shenyang , China.
Drug Dev Ind Pharm. 2014 Jan;40(1):126-35. doi: 10.3109/03639045.2012.752497. Epub 2013 Jan 22.
The aim of this study was to evaluate the applicability of POVACOAT™, a hydrophilic PVA copolymer, as a solid dispersion (SD) carrier for hot-melt extrusion (HME).
Bifendate (DDB), a water-insoluble drug, was chosen as the model drug. DDB was hot-melt extruded by a co-rotating twin screw extruder with POVACOAT™. The SD formability of POVACOAT™ was investigated by varying the composition ratios. Solid state characterization was evaluated by differential scanning calorimetry, powder X-ray diffraction, scanning electron microscopy and Fourier transformation infrared spectroscopy. In order to have a better knowledge of the mechanism of dissolution enhancement, dissolution study, phase solubility study and crystallization study of DDB from supersaturated solutions were performed. In addition, the storage stability of the extrudate containing 10% DDB was investigated.
Physical characterizations showed that DDB was amorphous up to 15% drug loading. The phase solubility study revealed an AL-type curve. Moreover, POVACOAT™ was found to have an inhibitory effect on crystallization from supersaturated solutions. Compared with the pure DDB and physical mixture, the dissolution rate and solubility of extrudates were significantly enhanced and the drug loading markedly affected the dissolution of SDs. Furthermore, the stability test indicated that 10% DDB-SD was stable during storage (40 °C/75% RH).
The results of this study demonstrate that POVACOAT™ is a valuable excipient for the formulation of solid dispersions prepared by HME to improve dissolution of poorly water-soluble drugs.
本研究旨在评估亲水性 PVA 共聚物 POVACOAT™作为热熔挤出(HME)用固体分散体(SD)载体的适用性。
选择难溶性药物双飞人(DDB)作为模型药物。通过双螺杆挤出机与 POVACOAT™共挤出熔融挤出 DDB。通过改变组成比来研究 POVACOAT™的 SD 形成能力。通过差示扫描量热法、粉末 X 射线衍射、扫描电子显微镜和傅里叶变换红外光谱对固态特征进行评估。为了更好地了解溶解增强的机制,对 DDB 从过饱和溶液中的溶解、相溶解度和结晶进行了研究。此外,还研究了含有 10%DDB 的挤出物的储存稳定性。
物理特性表明,DDB 在高达 15%的药物载量下呈无定形状态。相溶解度研究显示为 AL 型曲线。此外,发现 POVACOAT™对过饱和溶液中的结晶具有抑制作用。与纯 DDB 和物理混合物相比,挤出物的溶解速率和溶解度显著提高,药物载量明显影响 SD 的溶解。此外,稳定性试验表明,在储存过程中(40°C/75%RH),10%DDB-SD 稳定。
本研究结果表明,POVACOAT™是通过 HME 制备改善难溶性药物溶解的固体分散体的有价值的赋形剂。